Euro surveillance, 24(28). Centre Europeen pour la Surveillance Epidemiologique du SIDA Eurosurveillance Enkirch, T, Severi, E, Vennema, H, Thornton, L, Dean, J, Borg, M-L, Ciccaglione, A R, Bruni, R, Christova, I, Ngui, S L, Balogun, K, Němeček, V, Kontio, M, Takács, M, Hettmann, A, Korotinska, R, Löve, A, Avellón, A, Muñoz-Chimeno, M, de Sousa, R, Janta, D, Epštein, J, Klamer, S, Suin, V, Aberle, S W, Holzmann, H, Mellou, K, Ederth, J L, Sundqvist, L, Roque-Afonso, A-M, Filipović, S K, Poljak, M, Vold, L, Stene-Johansen, K, Midgley, S, Fischer, T K, Faber, M, Wenzel, J J, Takkinen, J & Leitmeyer, K 2019, ' Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area : towards comparable sequencing of hepatitis A virus ', Eurosurveillance (Online Edition), vol. 24, no. 28, pii=1800397 . https://doi.org/10.2807/1560-7917.ES.2019.24.28.1800397 Repisalud Instituto de Salud Carlos III (ISCIII)
Desalegn, H, Aberra, H, Berhe, N, Mekasha, B, Stene-Johansen, K, Krarup, H, Pereira, A P, Gundersen, S G & Johannessen, A 2018, ' Treatment of chronic hepatitis B in sub-Saharan Africa : 1-year results of a pilot program in Ethiopia ', BMC Medicine, vol. 16, no. 1, 234 . https://doi.org/10.1186/s12916-018-1229-x BMC Medicine BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Journal of Infectious Diseases, 213(1), 39-48. Oxford University Press Journal of Infectious Diseases, 213(1), 39. Oxford University Press Hermans, L E, Svicher, V, Pas, S D, Salpini, R, Alvarez, M, Ben Ari, Z, Boland, G, Bruzzone, B, Coppola, N, Seguin-Devaux, C, Dyda, T, Garcia, F, Kaiser, R, Köse, S, Krarup, H, Lazarevic, I, Lunar, M M, Maylin, S, Micheli, V, Mor, O, Paraschiv, S, Paraskevis, D, Poljak, M, Puchhammer-Stöckl, E, Simon, F, Stanojevic, M, Stene-Johansen, K, Tihic, N, Trimoulet, P, Verheyen, J, Vince, A, Weis, N, Yalcinkaya, T, Zidovec Lepej, S, Perno, C, Boucher, C A B, Wensing, A M J & HEPVIR working group of the European Society for translational antiviral research (ESAR) 2016, ' Combined Analysis of the Prevalence of drug Resistant Hepatitis B Virus in antiviral therapy Experienced patients in Europe (CAPRE) ', Journal of Infectious Diseases, vol. 213, no. 1, pp. 39-48 . https://doi.org/10.1093/infdis/jiv363
Colagrossi, L, Hermans, L E, Salpini, R, Di Carlo, D, Pas, S D, Alvarez, M, Ben-Ari, Z, Boland, G, Bruzzone, B, Coppola, N, Seguin-Devaux, C, Dyda, T, Garcia, F, Kaiser, R, Köse, S, Krarup, H, Lazarevic, I, Lunar, M M, Maylin, S, Micheli, V, Mor, O, Paraschiv, S, Paraskevis, D, Poljak, M, Puchhammer-Stöckl, E, Simon, F, Stanojevic, M, Stene-Johansen, K, Tihic, N, Trimoulet, P, Verheyen, J, Vince, A, Lepej, S Z, Weis, N, Yalcinkaya, T, Boucher, C A B, Wensing, A M J, Perno, C F, Svicher, V & HEPVIR working group of the European Society for translational antiviral research (ESAR) 2018, ' Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe ', BMC Infectious Diseases, vol. 18, no. 1, 251, pp. 1-12 . https://doi.org/10.1186/s12879-018-3161-2 BMC Infectious Diseases, 18:251. BioMed Central Ltd. BMC Infectious Diseases BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-12 (2018) HEPVIR working group of the European Society for translational antiviral research (ESAR) 2018, ' Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe ', BMC Infectious Diseases, vol. 18, no. 1, 251 . https://doi.org/10.1186/s12879-018-3161-2